Synapse - Carissa Chu

Results (14)

Clinical outcomes, genomic heterogeneity, and therapeutic considerations across histologic subtypes of urothelial carcinoma

Journal Article

Chu, C. E.; Chen, Z.; Whiting, K.; Ostrovnaya, I.; Lenis, A. T.; Clinton, T. N.; Rammal, R.; Ozcan, G. G.; Akbulut, D.; Basar, M.; more...
European Urology (2025)

Fulltext@MSK | Save

Molecular heterogeneity and immune infiltration drive clinical outcomes in upper tract urothelial carcinoma

Journal Article

Kim, K.; Alam, S. M.; Kuo, F.; Chen, Z.; Yip, W.; Katims, A. B.; Chu, C.; Lenis, A. T.; Hu, W.; Gokturk Ozcan, G.; more...
European Urology (2025)

Fulltext@MSK | Save

Natural history and genomic landscape of chemotherapy-resistant muscle-invasive bladder cancer

Journal Article

Lenis, A. T.; Whiting, K.; Ravichandran, V.; Tallman, J. E.; Alam, S. M.; Chu, C. E.; De Jesus Escano, M.; Bochner, E.; Katims, A.; Reisz, P. A.; more...
JCO Precision Oncology (2024)

Fulltext@MSK | Save

Immune mechanisms and molecular therapeutic strategies to enhance immunotherapy in non–muscle invasive bladder cancer: Invited review for special issue "Seminar: Treatment Advances and Molecular Biology Insights in Urothelial Carcinoma"

Review

Chu, C.; Pietzak, E.
Urologic Oncology: Seminars and Original Investigations (2023)

Fulltext@MSK | Save

Clinical and genomic landscape of FGFR3-altered urothelial carcinoma and treatment outcomes with erdafitinib: A real-world experience

Journal Article

Guercio, B. J.; Sarfaty, M.; Teo, M. Y.; Ratna, N.; Duzgol, C.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Regazzi, A. M.; Chen, Z.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Genomic landscape of urothelial carcinoma with divergent differentiation and histologic subtypes

Meeting Abstract

Chu, C.; Chen, Z.; Whiting, K.; Rammal, R.; Lenis, A.; Ozcan, G. G.; Akbulut, D.; Basar Yerebakan, M.; Chen, J. F.; Sirintrapun, S. J.; more...
Laboratory Investigation (2023)

Fulltext@MSK | Save

Scratching the surface: NECTIN-4 as a surrogate for enfortumab vedotin resistance

Editorial

Aggen, D. H.; Chu, C. E.; Rosenberg, J. E.
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Response Evaluation Criteria in Tumors of the Bladder (RECIT-Bladder) for future window of opportunity trials as a platform to accelerate drug development

Meeting Abstract

Gaffney, C.; Jiang, S.; de Jesus, M. R.; Chu, C. E.; Benfante, N.; Bajorin, D. F.; Donahue, T. F.; Rosenberg, J. E.; Iyer, G.; Bochner, B. H.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Assessing the utility of a cell-free tumor (ct)DNA assay (MSK-ACCESS) in patients (pts) with node-positive (N+) muscle-invasive bladder cancer (MIBC) undergoing neoadjuvant chemotherapy (NAC)